𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma

✍ Scribed by Winnie Yeo; T. W. T. Leung; S. F. Leung; Peter M. L. Teo; Anthony T. C. Chan; W. Y. Lee; Philip J. Johnson


Book ID
105994089
Publisher
Springer
Year
1996
Tongue
English
Weight
84 KB
Volume
38
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II study of gefitinib for the trea
✍ Daniel T. T. Chua; William I. Wei; Maria P. Wong; Jonathan S. T. Sham; John Nich πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 103 KB

## Abstract ## Background This single‐center, phase II study assessed the safety/tolerability and initial efficacy of gefitinib in patients with nasopharyngeal carcinoma (NPC) pretreated with platinum‐based chemotherapy. ## Methods Patients with recurrent and metastatic NPC who had treatment fai

A phase II study of chemotherapy of meta
✍ Robert P. Whitehead; Thomas R. Fleming; John S. Macdonald; Frederick R. Ahmann; πŸ“‚ Article πŸ“… 1991 πŸ› Springer US 🌐 English βš– 205 KB

The combination of 5-fluorouracil and cisplatin has shown encouraging results in single institution pilot studies in colorectal carcinoma. This phase II SWOG study was undertaken to further evaluate this treatment. Cisplatin was administered at a dose of 60 mg/M2 IV day 1, repeated every 21 days. 5-